REDW — Redwood Pharma AB Balance Sheet
0.000.00%
- SEK25.16m
- SEK24.34m
Annual balance sheet for Redwood Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 8.16 | 6.61 | 14.8 | 11.3 | 4.28 |
Net Total Receivables | 0.159 | 0.14 | 0.387 | 0.603 | 0.441 |
Prepaid Expenses | |||||
Total Current Assets | 8.44 | 6.87 | 15.2 | 12 | 4.82 |
Net Property, Plant And Equipment | — | — | — | — | 3.4 |
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Total Assets | 14.4 | 12.8 | 21.2 | 18.2 | 14.5 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.27 | 5.77 | 5.32 | 2.91 | 0.894 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 2.27 | 5.77 | 5.32 | 2.91 | 0.894 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 12.2 | 7.08 | 15.9 | 15.3 | 13.6 |
Total Liabilities & Shareholders' Equity | 14.4 | 12.8 | 21.2 | 18.2 | 14.5 |
Total Common Shares Outstanding |